Cell Culture Market

Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) & Region - Global Forecast to 2029

Report Code: BT 2561 Mar, 2024, by marketsandmarkets.com

The global cell culture market in terms of revenue was estimated to be worth $30.9 billion in 2024 and is poised to reach $57.9 billion by 2029, growing at a CAGR of 13.4% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Growth of the market can be attributed to factors such as growing focus on single-use technologies, increasing demand for novel therapeutics due to rising incidence of chronic diseases, and growth in biotechnology industry. However, high cost of cell biology research may hamper the growth of the market.

Cell Culture Market Size, Dynamics & Ecosystem

Cell Culture Market Size, Dynamics & Ecosystem

To know about the assumptions considered for the study, Request for Free Sample Report

Global Cell Culture Market Dynamics

DRIVER: Increasing fundings for cell-based research

Cell culture is integral in developing biological products to combat diseases like cancer and cardiovascular ailments. Globally, significant R&D efforts, backed by both governmental and private entities, are focused on pioneering cell therapy solutions. For instance, CellVovant, a biotech firm affiliated with the University of Bristol, secured USD 9.55 million (GBP 7.6 million) seed funding in January 2021 to accelerate the development of innovative stem cell therapies. Moreover, collaborations between public and private sectors are driving advancements; examples include research funding from organizations like the Ovarian Cancer Research Alliance and the European Research Council for investigating stem cell-based treatments for various diseases. With increasing research and funding directed towards addressing autoimmune, neurological, and cardiovascular disorders, the cell therapy market is poised for significant expansion.

RESTRAINT: High cost of cell biology research

Cell biology research, encompassing cutting-edge therapies like stem cell and gene therapies, demands top-tier equipment and reagents to ensure precise outcomes. As the need for stringent quality control and regulatory compliance rises, the cost of conducting cell biology research has significantly surged. The expensive nature of this research, coupled with budget constraints faced by researchers and small-scale pharmaceutical companies, poses hurdles in adopting microcarrier-based technologies for large-scale cell culture. These financial barriers impede the growth of the market, deterring potential adopters and customers.

OPPORTUNITY: Growth opportunities in emerging economies

Emerging countries such as India, China, and Brazil offer promising opportunities for market players, propelled by flourishing biopharmaceutical sectors, lower regulatory requirements, diverse healthcare markets, and government support. In the Asia Pacific, developing nations have become focal points for organizations seeking cost-effective manufacturing options, particularly in pharmaceuticals. Increasingly, pharmaceutical companies are outsourcing drug research activities to meet rising demands, particularly for vaccines and antibiotics, fuelling the expansion of cell culture in these emerging economies. With substantial investments in biotech, the Asia Pacific region is poised for significant growth, driven by factors like rising demand for new therapies, precision medicine, and advancements in technology such as artificial intelligence and big data analytics.

CHALLENGE: Disposal of plastic consumables

Cell culture is a flexible research method. However, it relies heavily on plastic consumables; large quantities of plastic waste are generated every year, affecting the environment adversely. Moreover, biopharmaceutical companies are increasingly adopting single-use bioprocessing systems and consumables due to their advantages, such as cost reduction, faster process development time, and lower capital investments. They also reduce utilities and water costs in cleaning, sterilization, and batch changeover time. However, there are serious concerns related to the disposal of solid waste materials from this alternative technology. Therefore, concern regarding disposal of plastic consumables might affect the market growth.

Global Cell Culture Industry Ecosystem Analysis

The cell culture market ecosystem comprises raw material suppliers, cell culture product manufacturers, and end users such as pharmaceutical and biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, CROs, CDMOs, and cell banks. Cell culture products manufacturers provide consumables including media, reagents, sera, vessels, and accessories, and equipment such as bioreactors, storage equipment, and other equipment.

Cell Culture Market Segmentation & Geographical Spread

Cell Culture Market Segmentation & Geographical Spread

To know about the assumptions considered for the study, download the pdf brochure

The biopharmaceutical production segment dominated cell culture industry in 2023.

Based on application, the cell culture market is segmented into five major segments, namely, biopharmaceutical production, diagnostics, tissue engineering & regenerative medicine, drug screening & development, and other applications. biopharmaceutical production, diagnostics, tissue engineering & regenerative medicine, drug screening & development, and other applications. Biopharmaceutical production segment is further categorized as monoclonal antibodies, vaccine production, and other therapeutic proteins. Tissue engineering & regenerative medicine segment is further divided based on cell and gene therapy, and others tissue engineering & regenerative medicine. In 2023, biopharmaceutical production segment dominated the market owing to rising approval and launches of monoclonal antibodies and biosimilars and increasing prevalence of infectious diseases.

The pharmaceutical & biotechnology companies segment dominated the cell culture industry in 2023.

Based on end user, the cell culture market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. In 2023, pharmaceutical & biotechnology companies segment held the largest market share in the global market owing to growing demand for biopharmaceuticals and personalized medicine, advancements in cell-based therapies and regenerative medicine, and the need for scalable and cost-effective production method.

North America was the largest regional market for the cell culture industry in 2023.

The global cell culture market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. North America accounted for the largest of market in 2023, followed by Europe and the Asia Pacific. Factors such as significant expenditure on R&D activities, presence of a well-established industry players, and growing demand for cell and gene therapies are responsible for the largest share of this segment.

Key players in the cell culture market include Thermo  Fisher Scientific Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US).

Scope of the Cell Culture Industry

Report Metric

Details

Market Revenue in 2024

$30.9 billion

Projected Revenue by 2029

$57.9 billion

Revenue Rate

Poised to Grow at a CAGR of 13.4%

Market Driver

Increasing fundings for cell-based research

Market Opportunity

Growth opportunities in emerging economies

This report categorizes the cell culture market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Consumables
    • Sera, Media, Reagents
      • Media
        • Serum-free media
        • Classical media & salts
        • Stem cell culture media
        • Chemically defined media
        • Specialty media
        • Other media
      • Reagents
        • Growth factors
        • Supplements
        • Buffers & chemicals
        • Cell dissociation reagents
        • Balanced salt solutions
        • Attachment & matrix factors
        • Antibiotics/Antimycotics
        • Cryoprotective Reagents
        • Contamination Detection Kits
        • Other cell culture reagents
      • Sera
        • Fetal Bovine sera
        • Adult Bovine sera
        • Other animal sera
    • Vessels
      • Cell factory systems/cell stacks
      • Roller/roux bottles
      • Flasks
      • Multiwall Plates
      • Petri dishes
  • Equipment
    • Bioreactors
      • Conventional Bioreactors
      • Single Use Bioreactor
    • Storage Equipment
      • Refrigerators & freezers
      • Cryostorage systems
    • Other Equipment
      • Filtration systems
      • Cell counters
      • Carbon dioxide incubators
      • Centrifuges
      • Autoclaves
      • Microscopes
      • Biosafety cabinets
      • Other supporting equipment

By Application

  • Biopharmaceutical Production
    • Monoclonal Antibody Production
    • Vaccine Production
    • Other Therapeutic Protein Production
  • Diagnostics
  • Tissue Engineering & Regenerative Medicine
    • Cell And Gene Therapy
    • Other Tissue Engineering and Regenerative Medicine Applications
  • Drug Screening & Development
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals And Diagnostic Laboratories
  • Research & Academic Institutes
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East
    • GCC Countries
      • Saudi Arabia (KSA)
      • United Arab Emirates (UAE)
      • Rest of GCC Countries (RoGCC)
    • Rest of Middle East (RoME)
  • Africa

Recent Developments of Cell Culture Industry:

  • In September 2023, Thermo Fisher Scientific launched the Gibco CTS Detachable Dynabeads, a groundbreaking platform with an innovative active-release mechanism designed for the clinical and commercial operation of cell therapy manufacturing.
  • In December 2023, Danaher acquired Abcam, a provider of validated antibodies, reagents, biomarkers, and assays crucial for drug discovery, life sciences research, and diagnostics. Within Danaher’s Life Sciences segment, Abcam will continue to operate independently, aligning with Danaher’s mission to advance disease understanding and expedite drug discovery.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 88)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY 
           1.5.1 VALUE UNIT
           1.5.2 VOLUME UNIT
    1.6 STAKEHOLDERS 
    1.7 LIMITATIONS 
    1.8 SUMMARY OF CHANGES 
    1.9 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 95)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MARKET
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 CELL CULTURE INDUSTRY SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
                    FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023)
           2.2.2 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
           2.2.3 TOP-DOWN APPROACH
                    FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 8 MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
          TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 110)
    FIGURE 10 CELL CULTURE MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    FIGURE 11 CELL CULTURE INDUSTRY, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    FIGURE 12 CELL CULTURE INDUSTRY, BY END USER, 2024 VS. 2029 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF CELL CULTURE INDUSTRY
 
4 PREMIUM INSIGHTS (Page No. - 113)
    4.1 CELL CULTURE MARKET OVERVIEW 
          FIGURE 14 INCREASING APPROVALS AND LAUNCHES OF BIOLOGICAL DRUGS TO SUPPORT MARKET GROWTH
    4.2 NORTH AMERICA: CELL CULTURE INDUSTRY, BY PRODUCT AND COUNTRY (2023) 
          FIGURE 15 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
    4.3 MARKET SHARE, BY APPLICATION, 2023 
          FIGURE 16 BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.4 MARKET SHARE, BY END USER, 2023 
          FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED END-USER MARKET IN 2023
    4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 116)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 2 CELL CULTURE INDUSTRY: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing support and funding from government and private organizations for cell-based research
                                TABLE 3 NIH FUNDING FOR STEM CELL-BASED RESEARCH, 2020–2024 (USD MILLION)
                                TABLE 4 FUNDING INVESTMENTS IN CELL & GENE THERAPY
                    5.2.1.2 Emerging cell culture technologies for production of cell-based viral vaccines
                    5.2.1.3 Growing popularity of monoclonal antibodies and biosimilars
                                TABLE 5 COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2023
                                FIGURE 20 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU (2012−2023)
                                FIGURE 21 NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED (2015−2024)
                    5.2.1.4 Adoption of single-use technologies
                    5.2.1.5 Growing focus of key players on product launches
                    5.2.1.6 Growth in advanced therapy medicinal products
                                FIGURE 22 CLINICAL TRIALS OVERVIEW OF TISSUE-ENGINEERED PRODUCTS (2019–2023)
                    5.2.1.7 Increasing incidence of infectious diseases
                                FIGURE 23 GLOBAL HIV EPIDEMIC, 2022
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of cell biology research
                    5.2.2.2 Limitations in producing high-density cell cultures
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising demand for 3D cell cultures
                    5.2.3.2 Emerging economies offer lucrative growth opportunities
                                TABLE 6 ASIA PACIFIC PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2023
                    5.2.3.3 Increasing focus on next-generation therapeutics
                                FIGURE 24 RSV VACCINE AND MAB SNAPSHOT (AS OF JANUARY 2024)
           5.2.4 CHALLENGES
                    5.2.4.1 Disposal of plastic consumables
                                TABLE 7 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
                    5.2.4.2 Ethical concerns related to cell usage
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
          FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
    5.4 PRICING ANALYSIS 
           5.4.1 AVERAGE SELLING PRICE OF CELL CULTURE EQUIPMENT AND CONSUMABLES
                    TABLE 8 AVERAGE SELLING PRICE RANGE OF CELL CULTURE EQUIPMENT AND CONSUMABLES, BY KEY PLAYER
           5.4.2 AVERAGE SELLING PRICE OF CELL CULTURE PRODUCTS, BY REGION
                    TABLE 9 AVERAGE SELLING PRICE RANGE OF SINGLE-USE ASSEMBLIES, BY REGION
                    TABLE 10 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000L IN DEVELOPED AND DEVELOPING COUNTRIES (2023)
    5.5 TECHNOLOGY ANALYSIS 
           5.5.1 KEY TECHNOLOGIES
                    5.5.1.1 Single-use technology
                                TABLE 11 ADVANTAGES OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS
                    5.5.1.2 Flow cytometry
                    5.5.1.3 Microscopy
           5.5.2 COMPLEMENTARY TECHNOLOGIES
                    5.5.2.1 High-throughput screening
                    5.5.2.2 Mass spectrometry
           5.5.3 ADJACENT TECHNOLOGIES
                    5.5.3.1 Microfluidics and organ-on-a-chip
                                TABLE 12 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE
                    5.5.3.2 3D bioprinting
    5.6 TRADE DATA 
          TABLE 13 IMPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)
          TABLE 14 EXPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)
          TABLE 15 IMPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS)
          TABLE 16 EXPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS)
    5.7 PATENT ANALYSIS 
           5.7.1 METHODOLOGY
           5.7.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
                    TABLE 17 PATENTS FILED, 2014–2024
           5.7.3 INNOVATION AND PATENT APPLICATIONS
                    FIGURE 26 TOTAL NUMBER OF PATENTS GRANTED, 2014–2024
           5.7.4 TOP APPLICANTS
                    FIGURE 27 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
                    TABLE 18 TOP 20 PATENT OWNERS IN CELL CULTURE, 2014–2024
                    TABLE 19 INDICATIVE LIST OF PATENTS IN CELL CULTURE MARKET, 2022–2024
    5.8 VALUE CHAIN ANALYSIS 
          FIGURE 28 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE
    5.9 SUPPLY CHAIN ANALYSIS 
          FIGURE 29 CELL CULTURE INDUSTRY: SUPPLY CHAIN ANALYSIS
    5.10 ECOSYSTEM ANALYSIS 
          FIGURE 30 MARKET: ECOSYSTEM ANALYSIS
           5.10.1 CELL CULTURE INDUSTRY: ROLE OF RAW MATERIAL VENDORS
                     TABLE 20 MARKET: ROLE OF RAW MATERIAL VENDORS
           5.10.2 CELL CULTURE INDUSTRY: ROLE OF PRODUCT PROVIDERS
                     TABLE 21 MARKET: ROLE OF PRODUCT PROVIDERS
           5.10.3 CELL CULTURE INDUSTRY: ROLE OF END USERS
                     TABLE 22 MARKET: ROLE OF END USERS
           5.10.4 CELL CULTURE INDUSTRY: ROLE OF REGULATORY AUTHORITIES
                     TABLE 23 MARKET: ROLE OF REGULATORY AUTHORITIES
    5.11 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 24 CELL CULTURE INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
           5.11.1 THREAT OF NEW ENTRANTS
           5.11.2 THREAT OF SUBSTITUTES
           5.11.3 BARGAINING POWER OF SUPPLIERS
           5.11.4 BARGAINING POWER OF BUYERS
           5.11.5 INTENSITY OF COMPETITIVE RIVALRY
    5.12 REGULATORY LANDSCAPE 
           5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 25 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 26 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 27 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 28 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.12.2 REGULATORY SCENARIO
                     TABLE 29 MARKET: REGULATORY GUIDELINES
    5.13 KEY CONFERENCES & EVENTS, 2024–2025 
           TABLE 30 MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024–2025
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL CULTURE PRODUCTS
           5.14.2 BUYING CRITERIA FOR CELL CULTURE
                     FIGURE 32 KEY BUYING CRITERIA FOR END USERS
                     TABLE 31 BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER
    5.15 INVESTMENT AND FUNDING SCENARIO 
 
6 CELL CULTURE MARKET, BY PRODUCT (Page No. - 176)
    6.1 INTRODUCTION 
          TABLE 32 CELL CULTURE INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
    6.2 CONSUMABLES 
          TABLE 33 CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 34 CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 35 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 36 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 37 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 38 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 39 MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 40 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.1 SERA, MEDIA, AND REAGENTS
                    TABLE 41 SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 42 SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 43 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 44 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 45 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 46 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 47 MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 48 GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.2.1.1 Media
                                TABLE 49 MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 50 MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 51 MEDIA MARKET, BY REGION, 2022-2029 (MILLION LITERS)
                                TABLE 52 NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 53 EUROPE: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 54 ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 55 LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 56 MIDDLE EAST: MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 57 GCC COUNTRIES: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.1.1 Serum-free media
                                             6.2.1.1.1.1 Serum-free media to hold largest market share
                                                               TABLE 58 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
                                                               TABLE 59 SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 60 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 61 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 62 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 63 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 64 MIDDLE EAST: SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 65 GCC COUNTRIES: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.1.2 Classical media & salts
                                             6.2.1.1.2.1 Increased usage of classical media and salts for efficient and scalable vaccine production to drive segment growth
                                                               TABLE 66 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
                                                               TABLE 67 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 68 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 69 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 70 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 71 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 72 MIDDLE EAST: CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 73 GCC COUNTRIES: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.1.3 Stem cell culture media
                                             6.2.1.1.3.1 Funding and grants for stem cell-based research and therapies to drive market
                                                               TABLE 74 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
                                                               TABLE 75 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 76 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 77 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 78 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 79 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 80 MIDDLE EAST: STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 81 GCC COUNTRIES: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.1.4 Chemically defined media
                                             6.2.1.1.4.1 Rising need for reproducibility, regulatory compliance, and precise control in cell culture systems to support growth
                                                               TABLE 82 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
                                                               TABLE 83 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 84 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 85 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 86 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 87 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 88 MIDDLE EAST: CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 89 GCC COUNTRIES: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.1.5 Specialty media
                                             6.2.1.1.5.1 Suitability for use in selective cell types in bioprocessing and biomanufacturing industries to boost adoption
                                                               TABLE 90 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
                                                               TABLE 91 SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 92 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 93 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 94 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 95 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 96 MIDDLE EAST: SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 97 GCC COUNTRIES: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.1.6 Other media
                                              TABLE 98 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS
                                              TABLE 99 OTHER MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 100 NORTH AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 101 EUROPE: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 102 ASIA PACIFIC: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 103 LATIN AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 104 MIDDLE EAST: OTHER MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 105 GCC COUNTRIES: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.2.1.2 Reagents
                                TABLE 106 REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 107 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 108 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 109 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 110 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 111 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 112 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 113 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.1 Growth factors
                                             6.2.1.2.1.1 Growth factors to hold largest share of reagents market
                                                               TABLE 114 GROWTH FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 115 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 116 EUROPE: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 117 ASIA PACIFIC: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 118 LATIN AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 119 MIDDLE EAST: GROWTH FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 120 GCC COUNTRIES: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.2 Supplements
                                             6.2.1.2.2.1 Acquisitions and expansions by key cell culture vendors to drive growth
                                                               TABLE 121 SUPPLEMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 122 NORTH AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 123 EUROPE: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 124 ASIA PACIFIC: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 125 LATIN AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 126 MIDDLE EAST: SUPPLEMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 127 GCC COUNTRIES: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.3 Buffers & chemicals
                                             6.2.1.2.3.1 Wide usage in cell cultures to promote market growth
                                                               TABLE 128 BUFFERS & CHEMICALS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 129 NORTH AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 130 EUROPE: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 131 ASIA PACIFIC: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 132 LATIN AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 133 MIDDLE EAST: BUFFERS & CHEMICALS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 134 GCC COUNTRIES: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.4 Cell dissociation reagents
                                             6.2.1.2.4.1 Ability to efficiently and gently detach adherent cells from culture surfaces to boost demand for dissociation reagents
                                                               TABLE 135 CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 136 NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 137 EUROPE: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 138 ASIA PACIFIC: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 139 LATIN AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 140 MIDDLE EAST: CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 141 GCC COUNTRIES: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.5 Balanced salt solutions
                                             6.2.1.2.5.1 Ability to maintain optimal physiological conditions for cell growth and experimentation to drive segment growth
                                                               TABLE 142 BALANCED SALT SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 143 NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 144 EUROPE: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 145 ASIA PACIFIC: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 146 LATIN AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 147 MIDDLE EAST: BALANCED SALT SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 148 GCC COUNTRIES: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.6 Attachment & matrix factors
                                             6.2.1.2.6.1 Rising adoption of 3D cell culture models to support market growth
                                                               TABLE 149 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 150 NORTH AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 151 EUROPE: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 152 ASIA PACIFIC: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 153 LATIN AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 154 MIDDLE EAST: ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 155 GCC COUNTRIES: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.7 Antibiotics/Antimycotics
                                             6.2.1.2.7.1 Risk of contamination to make use of antibiotics/antimycotics essential
                                                               TABLE 156 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 157 NORTH AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 158 EUROPE: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 159 ASIA PACIFIC: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 160 LATIN AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 161 MIDDLE EAST: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 162 GCC COUNTRIES: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.8 Cryoprotective reagents
                                             6.2.1.2.8.1 Ability to preserve cell viability during freezing and thawing to boost demand
                                                               TABLE 163 CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 164 NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 165 EUROPE: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 166 ASIA PACIFIC: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 167 LATIN AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 168 MIDDLE EAST: CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 169 GCC COUNTRIES: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.9 Contamination detection kits
                                             6.2.1.2.9.1 Rapid identification of microbial contaminants to drive usage of contamination detection kits
                                                               TABLE 170 CONTAMINATION DETECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 171 NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 172 EUROPE: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 173 ASIA PACIFIC: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 174 LATIN AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 175 MIDDLE EAST: CONTAMINATION DETECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 176 GCC COUNTRIES: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.2.10 Other reagents
                                              TABLE 177 OTHER REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 178 NORTH AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 179 EUROPE: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 180 ASIA PACIFIC: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 181 LATIN AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 182 MIDDLE EAST: OTHER REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 183 GCC COUNTRIES: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.2.1.3 Sera
                                TABLE 184 SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 185 SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 186 NORTH AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 187 EUROPE: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 188 ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 189 LATIN AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 190 MIDDLE EAST: SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 191 GCC COUNTRIES: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.3.1 Fetal bovine sera
                                             6.2.1.3.1.1 Fetal bovine sera to hold largest share
                                                               TABLE 192 FETAL BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 193 NORTH AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 194 EUROPE: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 195 ASIA PACIFIC: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 196 LATIN AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 197 MIDDLE EAST: FETAL BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 198 GCC COUNTRIES: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.3.2 Adult bovine sera
                                             6.2.1.3.2.1 Cost-effectiveness and use as a biochemical reagent in IVD to support adoption
                                                               TABLE 199 ADULT BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 200 NORTH AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 201 EUROPE: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 202 ASIA PACIFIC: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 203 LATIN AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                                               TABLE 204 MIDDLE EAST: ADULT BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                                               TABLE 205 GCC COUNTRIES: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                               6.2.1.3.3 Other animal sera
                                              TABLE 206 OTHER ANIMAL SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 207 NORTH AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 208 EUROPE: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 209 ASIA PACIFIC: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 210 LATIN AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 211 MIDDLE EAST: OTHER ANIMAL SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 212 GCC COUNTRIES: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.2 VESSELS
                    TABLE 213 VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 214 VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 215 NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 216 EUROPE: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 217 ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 218 LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 219 MIDDLE EAST: VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 220 GCC COUNTRIES: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.2.2.1 Cell factory systems/cell stacks
                               6.2.2.1.1 Efficient and scalable solutions for large-scale expansion to drive end-user adoption
                                              TABLE 221 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 222 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 223 EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 224 ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 225 LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 226 MIDDLE EAST: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 227 GCC COUNTRIES: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.2.2.2 Roller/roux bottles
                               6.2.2.2.1 Scalability, cost-effectiveness, and ease of handling to support growth
                                              TABLE 228 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 229 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 230 EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 231 ASIA PACIFIC: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 232 LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 233 MIDDLE EAST: ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 234 GCC COUNTRIES: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.2.2.3 Flasks
                               6.2.2.3.1 Advancements in cell culture flasks to boost segment growth
                                              TABLE 235 FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 236 NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 237 EUROPE: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 238 ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 239 LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 240 MIDDLE EAST: FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 241 GCC COUNTRIES: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.2.2.4 Multiwell plates
                               6.2.2.4.1 Increased adoption of multiwell plates to drive market
                                              TABLE 242 MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 243 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 244 EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 245 ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 246 LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 247 MIDDLE EAST: MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 248 GCC COUNTRIES: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.2.2.5 Petri dishes
                               6.2.2.5.1 Ease of use to drive demand
                                              TABLE 249 PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 250 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 251 EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 252 ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 253 LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 254 MIDDLE EAST: PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 255 GCC COUNTRIES: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.3 ACCESSORIES
                    6.2.3.1 Reduced preparation time and equipment performance improvements to drive market
                                TABLE 256 ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 257 NORTH AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 258 EUROPE: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 259 ASIA PACIFIC: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 260 LATIN AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 261 MIDDLE EAST: ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 262 GCC COUNTRIES: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.3 EQUIPMENT 
          TABLE 263 EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 264 EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 265 NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 266 EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 267 ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 268 LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 269 MIDDLE EAST: EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 270 GCC COUNTRIES: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.1 BIOREACTORS
                    TABLE 271 BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 272 BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 273 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 274 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 275 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 276 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 277 MIDDLE EAST: BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 278 GCC COUNTRIES: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.1.1 Conventional bioreactors
                               6.3.1.1.1 Utilization in large-scale manufacturing of drugs to drive market
                                              TABLE 279 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 280 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 281 EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 282 ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 283 LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 284 MIDDLE EAST: CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 285 GCC COUNTRIES: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.1.2 Single-use bioreactors
                               6.3.1.2.1 Lower operational costs and increased flexibility to boost demand
                                              TABLE 286 LIST OF COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS, BY KEY PLAYER
                                              TABLE 287 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 288 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 289 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 290 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 291 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 292 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 293 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.2 STORAGE EQUIPMENT
                    TABLE 294 STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 295 STORAGE EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 296 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 297 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 298 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 299 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 300 MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 301 GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.2.1 Refrigerators & freezers
                               6.3.2.1.1 Increasing need for storage solutions to propel market
                                              TABLE 302 REFRIGERATORS & FREEZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 303 NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 304 EUROPE: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 305 ASIA PACIFIC: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 306 LATIN AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 307 MIDDLE EAST: REFRIGERATORS & FREEZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 308 GCC COUNTRIES: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.2.2 Cryostorage systems
                               6.3.2.2.1 Benefits of long-term preservation of cell cultures to support growth
                                              TABLE 309 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 310 NORTH AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 311 EUROPE: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 312 ASIA PACIFIC: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 313 LATIN AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 314 MIDDLE EAST: CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 315 GCC COUNTRIES: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.3 OTHER EQUIPMENT
                    TABLE 316 OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 317 OTHER EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 318 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 319 EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 320 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 321 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 322 MIDDLE EAST: OTHER EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 323 GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.3.1 Filtration systems
                               6.3.3.1.1 Growing use in bioprocessing industry to boost demand
                                              TABLE 324 LIST OF FILTRATION SYSTEMS, BY KEY PLAYER
                                              TABLE 325 FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 326 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 327 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 328 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 329 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 330 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 331 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.3.2 Cell counters
                               6.3.3.2.1 Growing adoption of automated cell counters to propel market
                                              TABLE 332 LIST OF COMMERCIALLY AVAILABLE CELL COUNTERS, BY KEY PLAYER
                                              TABLE 333 CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 334 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 335 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 336 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 337 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 338 MIDDLE EAST: CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 339 GCC COUNTRIES: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.3.3 Carbon dioxide incubators
                               6.3.3.3.1 Increasing focus of research institutes on developing lab-scale incubators to drive market
                                              TABLE 340 CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS
                                              TABLE 341 CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 342 NORTH AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 343 EUROPE: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 344 ASIA PACIFIC: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 345 LATIN AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 346 MIDDLE EAST: CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 347 GCC COUNTRIES: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.3.4 Centrifuges
                               6.3.3.4.1 Increasing demand for bioproduction applications to drive adoption of centrifuges
                                              TABLE 348 CENTRIFUGES OFFERED BY KEY MARKET PLAYERS
                                              TABLE 349 CENTRIFUGES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 350 NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 351 EUROPE: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 352 ASIA PACIFIC: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 353 LATIN AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 354 MIDDLE EAST: CENTRIFUGES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 355 GCC COUNTRIES: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.3.5 Autoclaves
                               6.3.3.5.1 Reliance on single-use labware and equipment to affect demand for autoclaves
                                              TABLE 356 AUTOCLAVES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 357 NORTH AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 358 EUROPE: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 359 ASIA PACIFIC: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 360 LATIN AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 361 MIDDLE EAST: AUTOCLAVES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 362 GCC COUNTRIES: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.3.6 Microscopes
                               6.3.3.6.1 Inverted microscopes to show sustained demand in cell culture processes
                                              TABLE 363 MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 364 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 365 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 366 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 367 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 368 MIDDLE EAST: MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 369 GCC COUNTRIES: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.3.7 Biosafety cabinets
                               6.3.3.7.1 New product launches to drive market
                                              TABLE 370 BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS
                                              TABLE 371 BIOSAFETY CABINETS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 372 NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 373 EUROPE: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 374 ASIA PACIFIC: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 375 LATIN AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 376 MIDDLE EAST: BIOSAFETY CABINETS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 377 GCC COUNTRIES: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.3.3.8 Other supporting equipment
                                TABLE 378 OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS
                                TABLE 379 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 380 NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 381 EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 382 ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 383 LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 384 MIDDLE EAST: OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 385 GCC COUNTRIES: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
7 CELL CULTURE MARKET, BY APPLICATION (Page No. - 347)
    7.1 INTRODUCTION 
          TABLE 386 CELL CULTURE INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
    7.2 BIOPHARMACEUTICAL PRODUCTION 
          TABLE 387 MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
          TABLE 388 NORTH AMERICA: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 389 EUROPE: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 390 ASIA PACIFIC: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 391 LATIN AMERICA: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 392 MIDDLE EAST: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
          TABLE 393 GCC COUNTRIES: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 394 MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
           7.2.1 MONOCLONAL ANTIBODY PRODUCTION
                    7.2.1.1 Increasing approval and launch of mAb candidates to drive growth
                                TABLE 395 MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 396 NORTH AMERICA: MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 397 EUROPE: MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 398 ASIA PACIFIC: MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 399 LATIN AMERICA: MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 400 MIDDLE EAST: MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 401 GCC COUNTRIES: MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.2 VACCINE PRODUCTION
                    7.2.2.1 Rising incidence of infectious diseases to support market growth
                                TABLE 402 MARKET FOR VACCINE PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 403 NORTH AMERICA: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 404 EUROPE: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 405 ASIA PACIFIC: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 406 LATIN AMERICA: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 407 MIDDLE EAST: MARKET FOR VACCINE PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 408 GCC COUNTRIES: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
                    TABLE 409 CELL CULTURE INDUSTRY FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 410 NORTH AMERICA: MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 411 EUROPE: MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 412 ASIA PACIFIC: MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 413 LATIN AMERICA: MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 414 MIDDLE EAST: MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 415 GCC COUNTRIES: MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
    7.3 DIAGNOSTICS 
           7.3.1 ADVANCEMENTS AND ADOPTION OF NEW TECHNIQUES TO DRIVE SEGMENT GROWTH
                    TABLE 416 MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 417 NORTH AMERICA: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 418 EUROPE: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 419 ASIA PACIFIC: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 420 LATIN AMERICA: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 421 MIDDLE EAST: MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 422 GCC COUNTRIES: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
    7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 
          TABLE 423 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
          TABLE 424 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 425 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 426 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 427 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 428 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
          TABLE 429 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 430 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
           7.4.1 CELL & GENE THERAPY
                    7.4.1.1 New product launches and strategic alliances to drive segment growth
                                TABLE 431 MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 432 NORTH AMERICA: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 433 EUROPE: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 434 ASIA PACIFIC: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 435 LATIN AMERICA: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 436 MIDDLE EAST: MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 437 GCC COUNTRIES: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
           7.4.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
                    TABLE 438 MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 439 NORTH AMERICA: MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 440 EUROPE: MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 441 ASIA PACIFIC: MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 442 LATIN AMERICA: MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 443 MIDDLE EAST: MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 444 GCC COUNTRIES: MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
    7.5 DRUG SCREENING & DEVELOPMENT 
           7.5.1 INCREASING NEW DRUG DEVELOPMENT ACTIVITIES TO DRIVE MARKET
                    TABLE 445 CELL CULTURE INDUSTRY FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 446 NORTH AMERICA: MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 447 EUROPE: MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 448 ASIA PACIFIC: MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 449 LATIN AMERICA: MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 450 MIDDLE EAST: MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 451 GCC COUNTRIES: MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
    7.6 OTHER APPLICATIONS 
          TABLE 452 MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 453 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 454 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 455 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 456 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 457 MIDDLE EAST: MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 458 GCC COUNTRIES: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
8 CELL CULTURE MARKET, BY END USER (Page No. - 386)
    8.1 INTRODUCTION 
          TABLE 459 CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD
                    TABLE 460 RECENT DEVELOPMENTS IN PHARMA & BIOTECH SECTOR
                    TABLE 461 CELL CULTURE INDUSTRY FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 462 NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 463 EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 464 ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 465 LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 466 MIDDLE EAST: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 467 GCC COUNTRIES: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
    8.3 HOSPITALS & DIAGNOSTIC LABORATORIES 
           8.3.1 INCREASING DEMAND FOR CELL CULTURE PRODUCTS AND STRATEGIC ACTIVITIES TO DRIVE SEGMENT
                    TABLE 468 CELL CULTURE INDUSTRY FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 469 NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 470 EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 471 ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 472 LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 473 MIDDLE EAST: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 474 GCC COUNTRIES: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
    8.4 RESEARCH & ACADEMIC INSTITUTES 
           8.4.1 INCREASING FUNDING ACTIVITIES TO DRIVE MARKET
                    TABLE 475 CELL CULTURE INDUSTRY FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 476 NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 477 EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 478 ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 479 LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 480 MIDDLE EAST: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 481 GCC COUNTRIES: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
    8.5 OTHER END USERS 
          TABLE 482 CELL CULTURE INDUSTRY FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 483 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 484 EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 485 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 486 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 487 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 488 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
9 CELL CULTURE MARKET, BY REGION (Page No. - 403)
    9.1 INTRODUCTION 
          TABLE 489 CELL CULTURE INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
    9.2 NORTH AMERICA 
           9.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 33 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
                    TABLE 490 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 491 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 492 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 493 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 494 NORTH AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 495 NORTH AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 496 NORTH AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 497 NORTH AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 498 NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 499 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 500 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 501 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 502 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 503 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 504 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 505 NORTH AMERICA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.2.2 US
                    9.2.2.1 US to hold largest share of North American market
                                TABLE 506 INDICATIVE LIST OF CELL AND GENE THERAPIES APPROVED IN 2022
                                TABLE 507 US: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 508 US: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 509 US: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 510 US: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 511 US: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 512 US: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 513 US: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 514 US: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 515 US: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 516 US: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 517 US: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 518 US: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 519 US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 520 US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 521 US: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Increasing funding and investments for advancing cell-based therapies to boost market
                                TABLE 522 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 523 CANADA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 524 CANADA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 525 CANADA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 526 CANADA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 527 CANADA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 528 CANADA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 529 CANADA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 530 CANADA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 531 CANADA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 532 CANADA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 533 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 534 CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 535 CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 536 CANADA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
                    TABLE 537 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 538 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 539 EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 540 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 541 EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 542 EUROPE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 543 EUROPE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 544 EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 545 EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 546 EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 547 EUROPE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 548 EUROPE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 549 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 550 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 551 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 552 EUROPE: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Rising R&D investments and strategic alliances to drive market
                                TABLE 553 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 554 GERMANY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 555 GERMANY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 556 GERMANY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 557 GERMANY: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 558 GERMANY: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 559 GERMANY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 560 GERMANY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 561 GERMANY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 562 GERMANY: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 563 GERMANY: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 564 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 565 GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 566 GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 567 GERMANY: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Growth in life science industry and favorable government investments to support market
                                TABLE 568 UK: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 569 UK: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 570 UK: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 571 UK: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 572 UK: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 573 UK: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 574 UK: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 575 UK: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 576 UK: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 577 UK: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 578 UK: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 579 UK: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 580 UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 581 UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 582 UK: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.3.4 FRANCE
                    9.3.4.1 Rising number of cell-based research projects to enhance market growth
                                TABLE 583 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 584 FRANCE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 585 FRANCE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 586 FRANCE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 587 FRANCE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 588 FRANCE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 589 FRANCE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 590 FRANCE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 591 FRANCE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 592 FRANCE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 593 FRANCE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 594 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 595 FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 596 FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 597 FRANCE: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Strong government support to enhance R&D activities
                                TABLE 598 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 599 ITALY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 600 ITALY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 601 ITALY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 602 ITALY: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 603 ITALY: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 604 ITALY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 605 ITALY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 606 ITALY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 607 ITALY: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 608 ITALY: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 609 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 610 ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 611 ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 612 ITALY: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Booming biotechnology industry to aid market growth
                                TABLE 613 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 614 SPAIN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 615 SPAIN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 616 SPAIN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 617 SPAIN: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 618 SPAIN: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 619 SPAIN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 620 SPAIN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 621 SPAIN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 622 SPAIN: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 623 SPAIN: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 624 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 625 SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 626 SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 627 SPAIN: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 628 REST OF EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 629 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 630 REST OF EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 631 REST OF EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 632 REST OF EUROPE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 633 REST OF EUROPE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 634 REST OF EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 635 REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 636 REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 637 REST OF EUROPE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 638 REST OF EUROPE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 639 REST OF EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 640 REST OF EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 641 REST OF EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 642 REST OF EUROPE: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    9.4 ASIA PACIFIC 
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 34 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT
                    TABLE 643 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 644 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 645 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 646 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 647 ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 648 ASIA PACIFIC: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 649 ASIA PACIFIC: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 650 ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 651 ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 652 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 653 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 654 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 655 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 656 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 657 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 658 ASIA PACIFIC: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 China to register highest growth rate in Asia Pacific market
                                TABLE 659 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 660 CHINA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 661 CHINA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 662 CHINA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 663 CHINA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 664 CHINA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 665 CHINA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 666 CHINA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 667 CHINA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 668 CHINA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 669 CHINA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 670 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 671 CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 672 CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 673 CHINA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.4.3 JAPAN
                    9.4.3.1 Rising government initiatives and increasing investments in biotech to drive market
                                TABLE 674 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 675 JAPAN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 676 JAPAN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 677 JAPAN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 678 JAPAN: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 679 JAPAN: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 680 JAPAN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 681 JAPAN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 682 JAPAN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 683 JAPAN: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 684 JAPAN: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 685 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 686 JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 687 JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 688 JAPAN: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Favorable government support and expansion by key cell culture players to augment market growth
                                TABLE 689 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 690 INDIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 691 INDIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 692 INDIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 693 INDIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 694 INDIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 695 INDIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 696 INDIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 697 INDIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 698 INDIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 699 INDIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 700 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 701 INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 702 INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 703 INDIA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.4.5 SOUTH KOREA
                    9.4.5.1 Growing pharmaceutical sector to drive market
                                TABLE 704 SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 705 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 706 SOUTH KOREA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 707 SOUTH KOREA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 708 SOUTH KOREA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 709 SOUTH KOREA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 710 SOUTH KOREA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 711 SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 712 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 713 SOUTH KOREA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 714 SOUTH KOREA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 715 SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 716 SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 717 SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 718 SOUTH KOREA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.4.6 AUSTRALIA
                    9.4.6.1 Increasing prevalence of chronic diseases to drive market
                                TABLE 719 AUSTRALIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 720 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 721 AUSTRALIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 722 AUSTRALIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 723 AUSTRALIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 724 AUSTRALIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 725 AUSTRALIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 726 AUSTRALIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 727 AUSTRALIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 728 AUSTRALIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 729 AUSTRALIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 730 AUSTRALIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 731 AUSTRALIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 732 AUSTRALIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 733 AUSTRALIA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.4.7 REST OF ASIA PACIFIC
                    TABLE 734 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 735 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 736 REST OF ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 737 REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 738 REST OF ASIA PACIFIC: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 739 REST OF ASIA PACIFIC: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 740 REST OF ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 741 REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 742 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 743 REST OF ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 744 REST OF ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 745 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 746 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 747 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 748 REST OF ASIA PACIFIC: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 LATIN AMERICA: RECESSION IMPACT
                    TABLE 749 LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 750 LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 751 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 752 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 753 LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 754 LATIN AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 755 LATIN AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 756 LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 757 LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 758 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 759 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 760 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 761 LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 762 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 763 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 764 LATIN AMERICA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.5.2 BRAZIL
                    9.5.2.1 Rising prevalence of cancer and related research activities to support market growth
                                TABLE 765 BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 766 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 767 BRAZIL: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 768 BRAZIL: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 769 BRAZIL: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 770 BRAZIL: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 771 BRAZIL: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 772 BRAZIL: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 773 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 774 BRAZIL: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 775 BRAZIL: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 776 BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 777 BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 778 BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 779 BRAZIL: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.5.3 MEXICO
                    9.5.3.1 Growth in biopharmaceutical market to spur cell culture demand
                                TABLE 780 MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 781 MEXICO: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 782 MEXICO: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 783 MEXICO: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 784 MEXICO: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 785 MEXICO: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 786 MEXICO: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 787 MEXICO: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 788 MEXICO: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 789 MEXICO: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 790 MEXICO: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 791 MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 792 MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 793 MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 794 MEXICO: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 795 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 796 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 797 REST OF LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 798 REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 799 REST OF LATIN AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 800 REST OF LATIN AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 801 REST OF LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 802 REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 803 REST OF LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 804 REST OF LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 805 REST OF LATIN AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 806 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 807 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 808 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 809 REST OF LATIN AMERICA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    9.6 MIDDLE EAST 
           9.6.1 MIDDLE EAST: RECESSION IMPACT
                    TABLE 810 MIDDLE EAST: CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 811 MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 812 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 813 MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 814 MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 815 MIDDLE EAST: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 816 MIDDLE EAST: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 817 MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 818 MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 819 MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 820 MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 821 MIDDLE EAST: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 822 MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 823 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 824 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 825 MIDDLE EAST: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.6.2 GCC COUNTRIES
                    TABLE 826 GCC COUNTRIES: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 827 GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 828 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 829 GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 830 GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 831 GCC COUNTRIES: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 832 GCC COUNTRIES: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 833 GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 834 GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 835 GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 836 GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 837 GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 838 GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 839 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 840 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 841 GCC COUNTRIES: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
                    9.6.2.1 Saudi Arabia
                               9.6.2.1.1 Increasing focus of key players on expansion to drive market
                                              TABLE 842 SAUDI ARABIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                              TABLE 843 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 844 SAUDI ARABIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 845 SAUDI ARABIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 846 SAUDI ARABIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 847 SAUDI ARABIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 848 SAUDI ARABIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 849 SAUDI ARABIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 850 SAUDI ARABIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 851 SAUDI ARABIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 852 SAUDI ARABIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 853 SAUDI ARABIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                              TABLE 854 SAUDI ARABIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 855 SAUDI ARABIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 856 SAUDI ARABIA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
                    9.6.2.2 UAE
                               9.6.2.2.1 Developments in healthcare infrastructure and growing government initiatives to drive market
                                              TABLE 857 UAE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                              TABLE 858 UAE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 859 UAE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 860 UAE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 861 UAE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 862 UAE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 863 UAE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 864 UAE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 865 UAE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 866 UAE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 867 UAE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 868 UAE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                              TABLE 869 UAE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 870 UAE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 871 UAE: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
                    9.6.2.3 Rest of GCC Countries
                                TABLE 872 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 873 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 874 REST OF GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 875 REST OF GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 876 REST OF GCC COUNTRIES: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 877 REST OF GCC COUNTRIES: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 878 REST OF GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 879 REST OF GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 880 REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 881 REST OF GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 882 REST OF GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 883 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 884 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 885 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 886 REST OF GCC COUNTRIES: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
           9.6.3 REST OF MIDDLE EAST
                    TABLE 887 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 888 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 889 REST OF MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 890 REST OF MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 891 REST OF MIDDLE EAST: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 892 REST OF MIDDLE EAST: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 893 REST OF MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 894 REST OF MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 895 REST OF MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 896 REST OF MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 897 REST OF MIDDLE EAST: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 898 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 899 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 900 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 901 REST OF MIDDLE EAST: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    9.7 AFRICA 
           9.7.1 RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FUEL MARKET GROWTH
           9.7.2 AFRICA: RECESSION IMPACT
                    TABLE 902 AFRICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 903 AFRICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 904 AFRICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 905 AFRICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 906 AFRICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 907 AFRICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 908 AFRICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 909 AFRICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 910 AFRICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 911 AFRICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 912 AFRICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 913 AFRICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 914 AFRICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 915 AFRICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 916 AFRICA: CELL CULTURE INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 605)
     10.1 INTRODUCTION 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             TABLE 917 STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, 2022−2024
     10.3 REVENUE SHARE ANALYSIS 
             FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2019–2023 (USD BILLION)
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 36 CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
             TABLE 918 CELL CULTURE MARKET: DEGREE OF COMPETITION
     10.5 BRAND/PRODUCT COMPARATIVE ANALYSIS 
             FIGURE 37 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
             10.5.1 THERMO FISHER SCIENTIFIC INC.
             10.5.2 DANAHER CORPORATION
             10.5.3 MERCK KGAA
             10.5.4 SARTORIUS AG
             10.5.5 CORNING INCORPORATED
     10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS 
             10.6.1 STARS
             10.6.2 EMERGING LEADERS
             10.6.3 PERVASIVE PLAYERS
             10.6.4 PARTICIPANTS
                        FIGURE 38 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             10.6.5 COMPANY FOOTPRINT: KEY PLAYERS
                        FIGURE 39 CELL CULTURE MARKET: COMPANY FOOTPRINT
                        TABLE 919 CELL CULTURE MARKET: PRODUCT FOOTPRINT
                        TABLE 920 CELL CULTURE MARKET: APPLICATION FOOTPRINT
                        TABLE 921 CELL CULTURE MARKET: END-USER FOOTPRINT
                        TABLE 922 CELL CULTURE MARKET: REGIONAL FOOTPRINT
     10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES 
             10.7.1 PROGRESSIVE COMPANIES
             10.7.2 RESPONSIVE COMPANIES
             10.7.3 DYNAMIC COMPANIES
             10.7.4 STARTING BLOCKS
                        FIGURE 40 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
             10.7.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
                        TABLE 923 CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
                        TABLE 924 CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
     10.8 VALUATION AND FINANCIAL METRICS OF CELL CULTURE VENDORS 
             FIGURE 41 EV/EBITDA OF KEY VENDORS
             FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
     10.9 COMPETITIVE SCENARIO 
             10.9.1 PRODUCT LAUNCHES
                        TABLE 925 CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2024
             10.9.2 DEALS
                        TABLE 926 CELL CULTURE MARKET: DEALS, JANUARY 2021–FEBRUARY 2024
             10.9.3 EXPANSIONS
                        TABLE 927 CELL CULTURE MARKET: EXPANSIONS, JANUARY 2021–FEBRUARY 2024

11 COMPANY PROFILES (Page No. - 628)
     11.1 INTRODUCTION 
     11.2 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             11.2.1 THERMO FISHER SCIENTIFIC INC.
                        TABLE 928 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
                        FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
                        TABLE 929 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
                        TABLE 930 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
                        TABLE 931 THERMO FISHER SCIENTIFIC INC.: DEALS
                        TABLE 932 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
             11.2.2 DANAHER CORPORATION
                        TABLE 933 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT
                        TABLE 934 DANAHER CORPORATION: PRODUCTS OFFERED
                        TABLE 935 DANAHER CORPORATION: PRODUCT LAUNCHES
                        TABLE 936 DANAHER CORPORATION: DEALS
                        TABLE 937 DANAHER CORPORATION: EXPANSIONS
                        TABLE 938 DANAHER CORPORATION: OTHER DEVELOPMENTS
             11.2.3 MERCK KGAA
                        TABLE 939 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT
                        TABLE 940 MERCK KGAA: PRODUCTS OFFERED
                        TABLE 941 MERCK KGAA: PRODUCT LAUNCHES
                        TABLE 942 MERCK KGAA: DEALS
                        TABLE 943 MERCK KGAA: EXPANSIONS
             11.2.4 SARTORIUS AG
                        TABLE 944 SARTORIUS AG: BUSINESS OVERVIEW
                        FIGURE 46 SARTORIUS AG: COMPANY SNAPSHOT
                        TABLE 945 SARTORIUS AG: PRODUCTS OFFERED
                        TABLE 946 SARTORIUS AG: PRODUCT LAUNCHES
                        TABLE 947 SARTORIUS AG: DEALS
                        TABLE 948 SARTORIUS AG: EXPANSIONS
             11.2.5 CORNING INCORPORATED
                        TABLE 949 CORNING INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 47 CORNING INCORPORATED: COMPANY SNAPSHOT
                        TABLE 950 CORNING INCORPORATED: PRODUCTS OFFERED
                        TABLE 951 CORNING INCORPORATED: PRODUCT LAUNCHES
                        TABLE 952 CORNING INCORPORATED: DEALS
             11.2.6 FUJIFILM HOLDINGS CORPORATION
                        TABLE 953 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 48 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
                        TABLE 954 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
                        TABLE 955 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES
                        TABLE 956 FUJIFILM HOLDINGS CORPORATION: DEALS
                        TABLE 957 FUJIFILM HOLDINGS CORPORATION: EXPANSIONS
             11.2.7 BD
                        TABLE 958 BD: BUSINESS OVERVIEW
                        FIGURE 49 BD: COMPANY SNAPSHOT
                        TABLE 959 BD: PRODUCTS OFFERED
                        TABLE 960 BD: PRODUCT LAUNCHES
                        TABLE 961 BD: DEALS
             11.2.8 EPPENDORF SE
                        TABLE 962 EPPENDORF SE: BUSINESS OVERVIEW
                        FIGURE 50 EPPENDORF SE: COMPANY SNAPSHOT
                        TABLE 963 EPPENDORF SE: PRODUCTS OFFERED
                        TABLE 964 EPPENDORF SE: PRODUCT LAUNCHES
                        TABLE 965 EPPENDORF SE: DEALS
                        TABLE 966 EPPENDORF SE: EXPANSIONS
             11.2.9 LONZA
                        TABLE 967 LONZA: BUSINESS OVERVIEW
                        FIGURE 51 LONZA: COMPANY SNAPSHOT
                        TABLE 968 LONZA: PRODUCTS OFFERED
                        TABLE 969 LONZA: PRODUCT LAUNCHES
                        TABLE 970 LONZA: DEALS
             11.2.10 GETINGE AB
                        TABLE 971 GETINGE AB: BUSINESS OVERVIEW
                        FIGURE 52 GETINGE AB: COMPANY SNAPSHOT
                        TABLE 972 GETINGE AB: PRODUCTS OFFERED
                        TABLE 973 GETINGE AB: PRODUCT LAUNCHES
                        TABLE 974 GETINGE AB: DEALS
                        TABLE 975 GETINGE AB: EXPANSIONS
             11.2.11 AGILENT TECHNOLOGIES, INC.
                        TABLE 976 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
                        TABLE 977 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
                        TABLE 978 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
                        TABLE 979 AGILENT TECHNOLOGIES, INC.: DEALS
             11.2.12 HIMEDIA LABORATORIES
                        TABLE 980 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
                        TABLE 981 HIMEDIA LABORATORIES: PRODUCTS OFFERED
             11.2.13 BIO-TECHNE
                        TABLE 982 BIO-TECHNE: COMPANY OVERVIEW
                        FIGURE 54 BIO-TECHNE: COMPANY SNAPSHOT
                        TABLE 983 BIO-TECHNE: PRODUCTS OFFERED
                        TABLE 984 BIO-TECHNE: PRODUCT LAUNCHES
                        TABLE 985 BIO-TECHNE: DEALS
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies
     11.3 OTHER PLAYERS 
             11.3.1 MILTENYI BIOTEC
                        TABLE 986 MILTENYI BIOTEC: BUSINESS OVERVIEW
             11.3.2 STEMCELL TECHNOLOGIES
                        TABLE 987 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW
             11.3.3 SOLIDA BIOTECH GMBH
                        TABLE 988 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
             11.3.4 CAISSON LABS INC.
                        TABLE 989 CAISSON LABS INC.: BUSINESS OVERVIEW
             11.3.5 PROMOCELL GMBH
                        TABLE 990 PROMOCELL GMBH: BUSINESS OVERVIEW
             11.3.6 INVIVOGEN
                        TABLE 991 INVIVOGEN: BUSINESS OVERVIEW
             11.3.7 PAN-BIOTECH
                        TABLE 992 PAN-BIOTECH: BUSINESS OVERVIEW
             11.3.8 CELLEXUS
                        TABLE 993 CELLEXUS: BUSINESS OVERVIEW
             11.3.9 MEISSNER FILTRATION PRODUCTS, INC.
                        TABLE 994 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW
             11.3.10 ADOLF KÜHNER AG
                        TABLE 995 ADOLF KÜHNER AG: BUSINESS OVERVIEW
             11.3.11 ADVANCION CORPORATION
                        TABLE 996 ADVANCION CORPORATION: BUSINESS OVERVIEW
             11.3.12 BIOSPHERIX, LTD.
                        TABLE 997 BIOSPHERIX, LTD.: BUSINESS OVERVIEW
 
12 APPENDIX (Page No. - 764)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell culture market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell culture market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration, American Society for Cell Biology (ASCB), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT),  American Society for Gene and Cell Therapy (ASGCT), Centers of Disease Control and Prevention (CDC), International Serum Industry Association (ISIA), Pharmaceutical Research and Manufacturers of America (PhRMA), International Society for Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Society for In Vitro Biology (SIVB), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), American Type Culture Collection (ATCC), and the Alliance for Regenerative Medicine (ARM); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global cell culture market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, hospitals & diagnostic laboratories, research & academic institutes, CROs, and CMOs, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Cell Culture  Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell culture market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the cell culture business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Cell Culture  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Cell Culture  Market Size, and Share

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Cell culture refers to removing cells from an animal or plant and their subsequent growth in an artificial environment under controlled conditions. It is a process of growing cells outside their natural environment, typically in a laboratory setting. This technique allows researchers to study cells in a controlled environment, providing insights into their behavior, growth, metabolism, and response to various stimuli.

Stakeholders

  • Cell Culture Equipment and Reagents Manufacturers
  • Analytical and Life Science Instrumentation Companies
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Hospitals and Diagnostic Laboratories
  • Cell Banks

Report Objectives

  • To define, describe, and forecast the global cell culture market based on the product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall cell culture market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the cell culture market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific cell culture market into countries
  • A further breakdown of the Rest of European cell culture market into countries
  • A further breakdown of the Rest of Latin American cell culture market into countries
  • A further breakdown of the Rest of Middle East cell culture market into countries
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2561
Published ON
Mar, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Culture Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback